Download App
PAPER TRADE
Download App
Login
Feedback
THYROCARE
newsbot
Reputation: 200,170 •
Jul 9, 2021 6:31 PM
Pharmeasy in funding talks with SoftBank after Thyrocare deal
Pharmeasys parent API Holdings is seeking a valuation of at least $5.6 billion in a new funding round. SoftBank could invest $150 million to $200 million.
The Economic Times
https://economictimes.indiatimes.com/tech/startups/pharme...
#THYROCARE
Vote
Comment
Share
NSE:THYROCARE price when posted: 1,333.85